Headlines:

‘QR 678’ has been invented by celebrity cosmetic surgeons Dr Debraj Shome and Dr Rinky Kapoor, who are also the co-founders of The Esthetic Clinic. The formulation has received patents in the United States and India

How to prevent hair loss? Ways to reduce hair loss. Natural remedies to control hair fall. Well, these are some of the most searched topics on Google. Let’s be honest. We all are worried about hair loss. Is this a health condition or pattern of baldness we wonder? We try home remedies and also make frequent visits to the clinics. 

Male and female pattern hair loss, also known as androgenic alopecia, continues to remain a prominent area of concern, especially in the age groups of 25 and onwards. Clinicians and cosmetologists have been investigating modalities for a long time now. While non-surgical hair regrowth treatments like over-the-counter topical minoxidil, prescription oral finasteride, platelet-rich plasma (PRP) injections and light and laser therapy treatments help reduce hair fall when used in combination, they do leave adverse side effects.

Meet QR 678 — a proprietary, first in class hair fall and hair regrowth therapy, which is said to have revolutionised the treatment of hair fall. This formulation has been named QR678 inspired by the new generation ubiquitous presence of “Quick Response” QR code. 678 in Morse Code signifies “there is no answer”. This formulation has been named QR678 to signify a “Quick Response to a disease which earlier had no answer”.

QR 678 was invented by Dr Debraj Shome and Dr Rinky Kapoor, celebrity cosmetic surgeons from India and co-founders of The Esthetic Clinic, which are a chain of top-class dermatology and plastic surgery centres located in various cities in India. They observed that male pattern baldness, known as androgenic alopecia characterised by progressive hair loss in men growing at a rampant rate of 58% in males aged 30-50 years which initiated their urge to research and find a solution to this cosmetic issue leading to the invention of QR 678.

The therapy curbs hair fall and increases the thickness, number and density of existing hair follicles, offering greater hair coverage to the ones with alopecia. The formulation has received patents in the United States and in India. They ran comparative trials between the QR678 and PRP treatments with QR678 treatment causing almost 300% better results than the PRP.

For patients struggling from hair loss, mesotherapy is carried out using the QR 678 formulation, which are branded development elements, used by little practically pain-free administration into the scalp. Growth of hair calls for 5-8 sessions dispersed 2-3 weeks aside each. Typically 1 ml of solution is inserted per sitting, each sitting requires 15 minutes, no medical centre stay is needed, and every session costs approximately Rs 7,000. The comparative trials between the QR678 and PRP treatments have demonstrated that the therapy causes almost 300% better results than the PRP. The therapy, being a non-invasive, safe and pain-free plant-based formulation, also increases the uptake of the traditional hair transplant procedure by more than 50 %, as it is locally administered over the scalp skin by mesotherapy.

Dr Debraj Shome, clinical scientist and leader, R&D Team, QR678 and director at Esthetic Clinics said: “The hair-regrowth treatments available currently have many limitations, they cannot revive hair beyond a certain stage. QR678 is a process where growth factors are injected in the hair follicles, which not only arrests hair fall but also stimulates hair growth. QR678 is a non-surgical, pain-free and non-invasive procedure for the hair regrowth treatment which has shown very good results in over 100,000+ patients.”

QR678 is approved by the FDA as a minimally invasive hair regrowth treatment. As compared to PRP treatments, QR678:

– Contains multiple growth factors that apply towards holistic growth of hair and health of hair follicles

– Is much more comfortable and predicate than the PRP

– Does not have any side effects

– Has long-lasting results

– Has shown strong results in multiple hair loss conditions in over ten clinical trials, published in top American, peer-reviewed journals

– Can be used for hair regrowth in case of hair loss because of chemotherapy

– QR678 has received both Indian and USA patents and has demonstrated amazing results in over 21000 patients across various age groups.

– The formulation is now being used in ten plus countries and is scheduled for a European Union and United Kingdom launch in September 2021.

The therapy is utilised in top skin and hair clinics with key opinion leaders in 10+ countries. While 2020 was a slack year as the aesthetics industry itself contracted sharply and elective treatments decreased in lieu of Covid-19, 2021 saw a boost for QR 678. In the EU and UK markets, the launch is scheduled for September 1, after which the majority of the hair clinics in these markets will have access to the therapy. At present, the product is made at the QR 678 facilities which are located in Korea, manufacturing units are being set up in Europe and there is a European entity that deals in distribution all around the world.

Soon, QR678 would be filing a fresh patent globally, as the product is undergoing overhauling the patent would be even more efficacious. The team is also coming up with their own level of hair care products including nutraceuticals shampoos, serums and the likes.

About the author

The Optimist

Leave a Comment